WHIM syndrome

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 02:21, 1 July 2021 by Warner-admin (talk | contribs) (Text replacement - "{| class="wikitable" style="width: 50%; text-align:center;"" to "{| class="wikitable" style="width: 40%; text-align:center;"")
Jump to navigation Jump to search
Section editor
Tillman Benjamin-2.jpg
 Benjamin Tillman, MD
Vanderbilt University
Nashville, TN

WHIM: Warts, Hypogammaglobulinemia, Infections, Myelokathexis

1 regimens on this page
1 variants on this page


All lines of therapy

Plerixafor monotherapy

back to top

Regimen

Study Evidence
McDermott et al. 2019 Pilot, <20 pts

Growth factor therapy

References

  1. McDermott DH, Pastrana DV, Calvo KR, Pittaluga S, Velez D, Cho E, Liu Q, Trout HH 3rd, Neves JF, Gardner PJ, Bianchi DA, Blair EA, Landon EM, Silva SL, Buck CB, Murphy PM. Plerixafor for the treatment of WHIM syndrome. N Engl J Med. 2019 Jan 10;380(2):163-170. link to original article PubMed
Retrieved from "https://hemonc.org/w/index.php?title=WHIM_syndrome&oldid=51079"